Gregory P Sands - Net Worth and Insider Trading

Gregory P Sands Net Worth

The estimated net worth of Gregory P Sands is at least $16 Million dollars as of 2024-11-13. Gregory P Sands is the Director of QuinStreet Inc and owns about 537,263 shares of QuinStreet Inc (QNST) stock worth over $12 Million. Gregory P Sands is the 10% Owner of Corcept Therapeutics Inc and owns about 64,163 shares of Corcept Therapeutics Inc (CORT) stock worth over $4 Million. Gregory P Sands is also the 10% Owner of Molecular Templates Inc and owns about 0 shares of Molecular Templates Inc (MTEM) stock worth over $0. Details can be seen in Gregory P Sands's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Gregory P Sands has not made any transactions after 2018-12-12 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Gregory P Sands

Gregory P Sands Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Gregory P Sands owns 5 companies in total, including QuinStreet Inc (QNST) , Molecular Templates Inc (MTEM) , and Mattersight Corp (MATR) among others .

Click here to see the complete history of Gregory P Sands’s form 4 insider trades.

Insider Ownership Summary of Gregory P Sands

Ticker	Comapny	Transaction Date	Type of Owner
QNST	QuinStreet Inc	2018-12-12	director
MTEM	Molecular Templates Inc	2011-03-11	10 percent owner
MATR	Mattersight Corp	2011-11-30	10 percent owner
		2011-11-18	10 percent owner
		2008-03-25	10 percent owner

Gregory P Sands Latest Holdings Summary

Gregory P Sands currently owns a total of 3 stocks. Among these stocks, Gregory P Sands owns 537,263 shares of QuinStreet Inc (QNST) as of December 12, 2018, with a value of $12 Million and a weighting of 76.12%. Gregory P Sands owns 64,163 shares of Corcept Therapeutics Inc (CORT) as of March 25, 2008, with a value of $4 Million and a weighting of 23.88%. Gregory P Sands also owns 0 shares of Molecular Templates Inc (MTEM) as of March 11, 2011, with a value of $0 and a weighting of 0%.

Latest Holdings of Gregory P Sands

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
QNST	QuinStreet Inc	2018-12-12	537,263	22.00	11,817,100
CORT	Corcept Therapeutics Inc	2008-03-25	64,163	57.79	3,707,980
MTEM	Molecular Templates Inc	2011-03-11	0	0.33	0

Holding Weightings of Gregory P Sands

Gregory P Sands Form 4 Trading Tracker

According to the SEC Form 4 filings, Gregory P Sands has made a total of 0 transactions in QuinStreet Inc (QNST) over the past 5 years. The most-recent trade in QuinStreet Inc is the sale of 61,697 shares on December 12, 2018, which brought Gregory P Sands around $984,067.

According to the SEC Form 4 filings, Gregory P Sands has made a total of 0 transactions in Corcept Therapeutics Inc (CORT) over the past 5 years. The most-recent trade in Corcept Therapeutics Inc is the acquisition of 711,058 shares on March 25, 2008, which cost Gregory P Sands around $2 Million.

According to the SEC Form 4 filings, Gregory P Sands has made a total of 0 transactions in Molecular Templates Inc (MTEM) over the past 5 years. The most-recent trade in Molecular Templates Inc is the acquisition of 90 shares on March 11, 2011, which cost Gregory P Sands around $31,311.

Insider Trading History of Gregory P Sands

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Gregory P Sands Trading Performance

GuruFocus tracks the stock performance after each of Gregory P Sands's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Gregory P Sands is 19.72%. GuruFocus also compares Gregory P Sands's trading performance to market benchmark return within the same time period. The performance of stocks bought by Gregory P Sands within 3 months outperforms 7 times out of 10 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Gregory P Sands's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Gregory P Sands

Average Return

Average return per transaction

Outperforming Transactions

4 out of 10 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	17.05
Relative Return to S&P 500(%)	13.36

Gregory P Sands Ownership Network

Ownership Network List of Gregory P Sands

No Data

Ownership Network Relation of Gregory P Sands

Gregory P Sands Owned Company Details

What does QuinStreet Inc do?

Who are the key executives at QuinStreet Inc?

Gregory P Sands is the director of QuinStreet Inc. Other key executives at QuinStreet Inc include CFO Gregory Wong , director & 10 percent owner & Chief Executive Officer Douglas Valenti , and Chief Technology Officer Nina Bhanap .

QuinStreet Inc (QNST) Insider Trades Summary

Over the past 18 months, Gregory P Sands made no insider transaction in QuinStreet Inc (QNST). Other recent insider transactions involving QuinStreet Inc (QNST) include a net purchase of 12,500 shares made by Douglas Valenti , a net sale of 153,272 shares made by Gregory Wong , and a net sale of 50,000 shares made by Andrew T Sheehan .

In summary, during the past 3 months, insiders sold 41,855 shares of QuinStreet Inc (QNST) in total and bought 0 shares, with a net sale of 41,855 shares. During the past 18 months, 203,272 shares of QuinStreet Inc (QNST) were sold and 32,774 shares were bought by its insiders, resulting in a net sale of 170,498 shares.

QuinStreet Inc (QNST)'s detailed insider trading history can be found in Insider Trading Tracker table.

QuinStreet Inc Insider Transactions

No Available Data

What does Molecular Templates Inc do?

Who are the key executives at Molecular Templates Inc?

Gregory P Sands is the 10 percent owner of Molecular Templates Inc. Other key executives at Molecular Templates Inc include 10 percent owner Biotech Target N V , Chief Medical Officer Maurizio Voi , and CFO & Treasurer Sean Mclennan .

Molecular Templates Inc (MTEM) Insider Trades Summary

Over the past 18 months, Gregory P Sands made no insider transaction in Molecular Templates Inc (MTEM). Other recent insider transactions involving Molecular Templates Inc (MTEM) include a net purchase of 4,505,319 shares made by Biotech Target N V ,

In summary, during the past 3 months, insiders sold 0 shares of Molecular Templates Inc (MTEM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Molecular Templates Inc (MTEM) were sold and 533,688 shares were bought by its insiders, resulting in a net purchase of 533,688 shares.

Molecular Templates Inc (MTEM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Molecular Templates Inc Insider Transactions

No Available Data

What does Mattersight Corp do?

Who are the key executives at Mattersight Corp?

Gregory P Sands is the 10 percent owner of Mattersight Corp. Other key executives at Mattersight Corp include director & CFO David B Mullen , director & 10 percent owner Tench Coxe , and 10 percent owner Jeffrey W Bird .

Mattersight Corp (MATR) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Mattersight Corp (MATR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Mattersight Corp (MATR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Mattersight Corp (MATR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Mattersight Corp Insider Transactions

No Available Data

What does Dex Liquidating Co do?

Who are the key executives at Dex Liquidating Co?

Gregory P Sands is the 10 percent owner of Dex Liquidating Co. Other key executives at Dex Liquidating Co include other: Former Director Younger William H Jr , V.P. & Finance & CFO & Secretary Newell Robert Y Iv , and VP,Worldwide Sales & Marketing Liam Burns .

Dex Liquidating Co (DXTRQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Dex Liquidating Co (DXTRQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Dex Liquidating Co (DXTRQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Dex Liquidating Co (DXTRQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Dex Liquidating Co Insider Transactions

No Available Data

What does Corcept Therapeutics Inc do?

Who are the key executives at Corcept Therapeutics Inc?

Gregory P Sands is the 10 percent owner of Corcept Therapeutics Inc. Other key executives at Corcept Therapeutics Inc include Chief Development Officer William Guyer , CHIEF FINANCIAL OFFICER Gary Charles Robb , and Chief Accounting Officer Joseph Douglas Lyon .

Corcept Therapeutics Inc (CORT) Insider Trades Summary

Over the past 18 months, Gregory P Sands made no insider transaction in Corcept Therapeutics Inc (CORT). Other recent insider transactions involving Corcept Therapeutics Inc (CORT) include a net sale of 70,000 shares made by Joseph Douglas Lyon , a net sale of 28,750 shares made by Swisher Daniel N Jr , and a net sale of 225,000 shares made by Sean Maduck .

In summary, during the past 3 months, insiders sold 44,101 shares of Corcept Therapeutics Inc (CORT) in total and bought 0 shares, with a net sale of 44,101 shares. During the past 18 months, 517,899 shares of Corcept Therapeutics Inc (CORT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 517,899 shares.

Corcept Therapeutics Inc (CORT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Corcept Therapeutics Inc Insider Transactions

No Available Data

Gregory P Sands Mailing Address

Above is the net worth, insider trading, and ownership report for Gregory P Sands. You might contact Gregory P Sands via mailing address: 755 Page Mill Road, Suite A-200, Palo Alto Ca 94304-1005.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.